1 / 8

Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, Growth Trends By 2033

Global non-alcoholic steatohepatitis (nash) market size is expected to reach $14.53 Bn by 2028 at a rate of 33.7%, segmented as by type, solid, liquid<br>

bhuvantbrc
Download Presentation

Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, Growth Trends By 2033

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-Alcoholic Steatohepatitis (NASH) Market Report 2024 Market Size, Trends and Global Forecast 2024-2033

  2. Non-Alcoholic Steatohepatitis (NASH) Market Segments The Business Research Company segments it’s Non-Alcoholic Steatohepatitis (NASH) Market report as: Solid, Liquid By Type Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products By Product By Disease Cause Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity By Sales Channel Hospital Pharmacy, Retail Pharmacy, Online Provider By Application Oral, Parenteral

  3. Non-Alcoholic Steatohepatitis (NASH) Market Statistics It will grow from $3.33 billion in 2023 to $4.54 billion in 2024 at a compound annual growth rate (CAGR) of 36.3%. It will grow to $14.53 billion in 2028 at a compound annual growth rate (CAGR) of 33.7% Click Here To Get A Sample Report

  4. Key Market Drivers And Trends • Drivers The rising cases of obesity is driving the demand for the non-alcoholic steatohepatitis (NASH) market going forward. Trends Technological advancement is a key trend gaining popularity in the non-alcoholic steatohepatitis (NASH) market. • Region North America was the largest region in the non alcoholic steatohepatitis (NASH) market share in 2023. The regions covered in the non-alcoholic steatohepatitis (nash) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

  5. Key Market Players • Major players in the Non-Alcoholic Steatohepatitis (NASH) Market are: • NGM Biopharmaceuticals Inc • Novartis AG • AstraZeneca plc • GlaxoSmithKline plc • F. Hoffmann-La Roche AG • And more. Get More Information On The Non-Alcoholic Steatohepatitis (NASH) Market Report

  6. 5 Reasons Why TBRC Is The Solution You Need • Measure the impact of high global inflation on market growth • Outperform competitors using forecast data and the drivers and trends shaping the market • Get a comprehensive market sizing report with a truly global perspective covering 60+ geographies from The Business Research Company, with data from 2017 to 2024 and forecasts up to 2033. • Assess the Russia-Ukraine war’s impact on commodity supply and its direct and indirect impact on all the markets • Benchmark performance against key competitors.

  7. Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE ✆ +44 207 1930 708 How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 ✆ +91 8897263534 info@tbrc.info

  8. Your Growth Insights Partner

More Related